Abstract
Malignant Melanoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.
(with clinical comments by Olivia Dolan)
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology. 2000;36:387–402.
Bhawan J. Non-melanocytic mimics of melanocytic neoplasms. Histopathology. 2012;60:715–30.
Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145:427–34.
Brenn T. Pitfalls in the evaluation of melanocytic lesions. Histopathology. 2012;60:690–705.
Calonje JE, Brenn T, Lazar AJ, McKee PH. McKee’s pathology of the skin with clinical correlations. 4th ed. Philadelphia: Elsevier Saunders; 2012.
Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caracò C, Cochran AJ, Cook MG, Drzewiecki KT, Essner R, Even-Sapir E, Eggermont AM, Stopar TG, Ingvar C, Mihm MC Jr, McCarthy SW, Mozzillo N, Nieweg OE, Scolyer RA, Starz H, Thompson JF, Trifirò G, Viale G, Vidal-Sicart S, Uren R, Waddington W, Chiti A, Spatz A, Testori A. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging. 2009;36:1713–42.
Cheng L, Lopez-Beltran A, Massari F, MacLennan GT, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. Mod Pathol. 2017;31:24–38.
Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705–27.
Cook MG, Di Palma S. Pathology of sentinel lymph nodes for melanoma. J Clin Pathol. 2008;61:897–902.
Culpepper KS, Granter SR, McKee PH. My approach to atypical melanocytic lesions. J Clin Pathol. 2004;57:1121–31.
DeWit NJW, Van Muijen GNP, Ruiter DJ. Immunohistochemistry in melanocytic proliferative lesions. Histopathology. 2004;44:517–41.
Elder DE, Massi D, Scolyer RA, Willemze R, editors. WHO classification of skin tumours. 4th ed. Lyon: IARC; 2018.
Elder DE, Murphy GF. Melanocytic tumors of the skin. Atlas of tumor pathology. 3rd series. Fascicle 2. AFIP: Washington; 1991.
Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF. Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92.
In’t Hout FE, Haydu LE, Murali R, Bonenkamp JJ, Thompson JF, Scolyer RA. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma. Ann Surg. 2012;255:1165–70.
Kirkham N. The differential diagnosis of thin malignant melanoma. Curr Diagn Pathol. 2003;9:281–6.
Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, Gore ME, Lorigan P, MacKie R, Nathan P, Peach H, Powell B, Walker C. Revised UK guidelines for the management of malignant melanoma. Br J Dermatol. 2010;163:238–56.
Melanoma Skin Cancer Statistics. Cancer Research UK; 2018. 21 Oct 2018. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/melanoma-skin-cancer.
Moore DA, Pringle JH, Saldanha GS. Prognostic tissue markers in melanoma. Histopathology. 2012;60:679–89.
National Institute for Health and Care Excellence (NICE). Suspected cancer: recognition and referral. NICE guideline; 2015a. nice.org.uk/guidance/ng12.
National Institute for Health and Care Excellence (NICE). Melanoma: assessment and management. NICE guideline; 2015b. nice.org.uk/guidance/ng14.
Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C. A meta-analysis of nevus-associated melanoma: Prevalence and practical implications. J Am Acad Dermatol. 2017;77:938–45.
Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs’ micrographic surgery. J Am Acad Dermatol. 1998;39:79–97.
Svedman FC, Pillas D, Taylor A, Kaur M, Linder R, Hansson J. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. Clin Epidemiol. 2016;8:109–22.
The Royal College of Pathologists. Cancer Datasets (Basal cell carcinoma, Malignant Melanoma, Squamous Cell Carcinoma, Primary Cutaneous Adnexal Carcinomas) and Tissue Pathways (Inflammatory and Non-neoplastic Dermatoses and Non-neoplastic Lesions); (n.d.). https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html.
Weedon D. Skin pathology. 3rd ed. London: Churchill Livingstone; 2009.
Weyers W, Euler M, Diaz-Cascajo C, Schill W, Bonczkowitz M. Classification of cutaneous malignant melanoma. Cancer. 1999;86:288–99.
Zettersten E, Sagebiel RW, Miller JR 3rd, Tallapureddy S, Leong SP, Kashani-Sabet M. Prognostic factors in patients with thick cutaneous melanoma (>4 mm). Cancer. 2002;94:1049–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Boyle, D.P. (2020). Malignant Melanoma. In: Boyle, D., Allen, D. (eds) Histopathology Reporting. Springer, Cham. https://doi.org/10.1007/978-3-030-27828-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-030-27828-1_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27827-4
Online ISBN: 978-3-030-27828-1
eBook Packages: MedicineMedicine (R0)